Melanocortin 4 Receptor Pathway Dysfunction in Obesity: Patient Stratification Aimed at MC4R Agonist Treatment.

J Clin Endocrinol Metab · 2018 · PMC7263790 · PMID 29726959

Europe PMC DOI

hedged sentence

0.0980

closest p · 2.0× alpha

0.0980

boldest claim

The sentences

a strong trendP = 0.098so close (0.05 < p ≤ 0.1)

However, we still observed a strong trend toward an association with higher BMI ( β = 0.52, SE = 0.32, P = 0.098) when compared with noncarrier or WT individuals ( Fig. 4D ).

also in 5,725 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.